These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
664 related articles for article (PubMed ID: 16288052)
1. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052 [TBL] [Abstract][Full Text] [Related]
2. Crosstalk between EGFR and extranuclear steroid receptors. Migliaccio A; Castoria G; Di Domenico M; Ciociola A; Lombardi M; De Falco A; Nanayakkara M; Bottero D; De Stasio R; Varricchio L; Auricchio F Ann N Y Acad Sci; 2006 Nov; 1089():194-200. PubMed ID: 17261767 [TBL] [Abstract][Full Text] [Related]
3. Sex-steroid hormones and EGF signalling in breast and prostate cancer cells: targeting the association of Src with steroid receptors. Auricchio F; Migliaccio A; Castoria G Steroids; 2008 Oct; 73(9-10):880-4. PubMed ID: 18342899 [TBL] [Abstract][Full Text] [Related]
4. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
5. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches. Hoffmann J; Sommer A J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262 [TBL] [Abstract][Full Text] [Related]
6. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells. Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155 [TBL] [Abstract][Full Text] [Related]
7. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Huang Y; Li X; Jiang J; Frank SJ Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991 [TBL] [Abstract][Full Text] [Related]
8. Rapid signalling pathway activation by androgens in epithelial and stromal cells. Castoria G; Lombardi M; Barone MV; Bilancio A; Di Domenico M; De Falco A; Varricchio L; Bottero D; Nanayakkara M; Migliaccio A; Auricchio F Steroids; 2004 Aug; 69(8-9):517-22. PubMed ID: 15288763 [TBL] [Abstract][Full Text] [Related]
9. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor. Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741 [TBL] [Abstract][Full Text] [Related]
10. Interplay between steroid receptors and neoplastic progression in sarcoma tumors. Fiorelli A; Ricciardi C; Pannone G; Santoro A; Bufo P; Santini M; Serpico R; Rullo R; Pierantoni GM; Di Domenico M J Cell Physiol; 2011 Nov; 226(11):2997-3003. PubMed ID: 21302296 [TBL] [Abstract][Full Text] [Related]
11. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells. Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401 [TBL] [Abstract][Full Text] [Related]
12. The androgen receptor and prostate cancer invasion. Bonaccorsi L; Muratori M; Marchiani S; Forti G; Baldi E Mol Cell Endocrinol; 2006 Feb; 246(1-2):157-62. PubMed ID: 16376012 [TBL] [Abstract][Full Text] [Related]
13. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959 [TBL] [Abstract][Full Text] [Related]
14. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells. Mukherjee B; Mayer D Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894 [TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells. Fan P; Wang J; Santen RJ; Yue W Cancer Res; 2007 Feb; 67(3):1352-60. PubMed ID: 17283173 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor alpha tyrosine-phosphorylated peptide. Varricchio L; Migliaccio A; Castoria G; Yamaguchi H; de Falco A; Di Domenico M; Giovannelli P; Farrar W; Appella E; Auricchio F Mol Cancer Res; 2007 Nov; 5(11):1213-21. PubMed ID: 18025264 [TBL] [Abstract][Full Text] [Related]
17. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation. Léotoing L; Manin M; Monté D; Baron S; Communal Y; Lours C; Veyssière G; Morel L; Beaudoin C J Mol Endocrinol; 2007 Aug; 39(2):151-62. PubMed ID: 17693613 [TBL] [Abstract][Full Text] [Related]
18. Regulation of androgen receptor activity by tyrosine phosphorylation. Guo Z; Dai B; Jiang T; Xu K; Xie Y; Kim O; Nesheiwat I; Kong X; Melamed J; Handratta VD; Njar VC; Brodie AM; Yu LR; Veenstra TD; Chen H; Qiu Y Cancer Cell; 2006 Oct; 10(4):309-19. PubMed ID: 17045208 [TBL] [Abstract][Full Text] [Related]
19. Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway. Amorino GP; Deeble PD; Parsons SJ Oncogene; 2007 Feb; 26(5):745-56. PubMed ID: 16862179 [TBL] [Abstract][Full Text] [Related]
20. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor. Kraus S; Gioeli D; Vomastek T; Gordon V; Weber MJ Cancer Res; 2006 Nov; 66(22):11047-54. PubMed ID: 17108144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]